Over the years, Hyamax has grown in brand awareness in the Middle East, based on the quality of its products, and has gradually gained a major share of the Middle East non-surgical medical aesthetic market.
This year, Hyamax was again the focus of the exhibition at Dubai Derma. There was a constant stream of customers and doctors visiting the stand, showing great interest in Hyamax products and having a good conversation with Hyamed's sales staff.
Originally from Switzerland, we have been specialising in the development and manufacture of injectable hyaluronic acid products for over 12 years. With the patented Hyamax® hyaluronic acid cross-linking technology, single phase hyaluronic acid cross-linking technology and CE mark in 2012, we are able to manufacture a full range of hyaluronic acid fillers and hydrating injectables to meet the needs of the non-surgical medical aesthetic market in all aspects.
Hyamax's commitment to safety and aesthetics remains strong and our R&D and business teams are active at the world's leading medical aesthetics and dermatology conferences, courses and exhibitions. We are constantly learning about the most cutting-edge theories and technologies in the industry and engaging in friendly academic exchanges and business collaborations.
With this congress and exhibition, Hyamax is further promoting our brand to the world and taking in a lot of good experiences.
Come and visit us again at the AMWC World Congress of Cosmetic Anti-Aging in beautiful Monaco from 29 March to 1 April.